Theralink Technologies Inc (THER)

[tr1205]

As long as we’re Blue Skying it think bigger. Past successful phase 2 & 3.
What if you used the same number of outstanding shares and it was bought out by big Pharma. For instance...

Onyx Pharmaceuticals, acquired by Amgen amgn in 2013 for $9.7 billion. Former Amgen executive Terry Rosen started Flexus Biosciences and sold it 17 months later for $1.3 billion.

So here’s a what if happy dreams for all us longs. Say they knocked it out the park in trials and FDA approvals. What if we used $9.7B from the above example, that is in the neighborhood of $39.63 per share. Of course there would be a lot more they would need to do make that happen in the next few years to work. But sweet dreams... what would your holding be worth? Makes you think twice about selling in the pennies versus holding strong. I think the total investors in this company is only about ~178 now before the crowd rushes in.

Anyway just a Sunday afternoon dream. Happy trading on Monday.